v3.26.1
Condensed Statement of Stockholders Deficiency (Unaudited) - USD ($)
Total
Common Stock
Additional Paid-In Capital
Subscription Receivable
Accumulated Deficit
Balance, shares at Dec. 31, 2024   252,408,222      
Balance, amount at Dec. 31, 2024 $ (2,458,746) $ 252,408 $ 76,004,704 $ 0 $ (78,715,858)
Vesting of restricted stock, shares   4,725,000      
Vesting of restricted stock, amount 1,120,125 $ 4,725 1,115,400 0 0
Net Loss (1,539,129) $ 0 0 0 (1,539,129)
Balance, shares at Mar. 31, 2025   257,133,222      
Balance, amount at Mar. 31, 2025 (2,877,750) $ 257,133 77,120,104 0 (80,254,987)
Balance, shares at Dec. 31, 2024   252,408,222      
Balance, amount at Dec. 31, 2024 (2,458,746) $ 252,408 76,004,704 0 (78,715,858)
Net Loss (1,854,316)        
Balance, shares at Jun. 30, 2025   257,333,222      
Balance, amount at Jun. 30, 2025 (3,192,937) $ 257,333 77,136,474 (16,570) (80,570,174)
Balance, shares at Mar. 31, 2025   257,133,222      
Balance, amount at Mar. 31, 2025 (2,877,750) $ 257,133 77,120,104 0 (80,254,987)
Net Loss (315,187) $ 0 0 0 (315,187)
Common stock issued for a stock subscription receivable, shares   200,000      
Common stock issued for a stock subscription receivable, amount 0 $ 200 16,370 (16,570) 0
Balance, shares at Jun. 30, 2025   257,333,222      
Balance, amount at Jun. 30, 2025 (3,192,937) $ 257,333 77,136,474 (16,570) (80,570,174)
Balance, shares at Dec. 31, 2025   258,690,253      
Balance, amount at Dec. 31, 2025 (3,984,972) $ 258,690 77,235,150 0 (81,478,812)
Net Loss (315,842) $ 0 0 0 (315,842)
Balance, shares at Mar. 31, 2026   258,690,253      
Balance, amount at Mar. 31, 2026 (4,300,814) $ 258,690 77,235,150 0 (81,794,654)
Balance, shares at Dec. 31, 2025   258,690,253      
Balance, amount at Dec. 31, 2025 (3,984,972) $ 258,690 77,235,150 0 (81,478,812)
Net Loss $ (599,982)        
Common stock issued for conversion of convertible note payable, shares 50,000        
Balance, shares at Jun. 30, 2026   261,585,588      
Balance, amount at Jun. 30, 2026 $ (4,442,816) $ 261,585 77,374,393 0 (82,078,794)
Balance, shares at Mar. 31, 2026   258,690,253      
Balance, amount at Mar. 31, 2026 (4,300,814) $ 258,690 77,235,150 0 (81,794,654)
Net Loss (284,140) $ 0 0 0 (284,140)
Common stock issued for conversion of convertible note payable, shares   895,335      
Common stock issued for conversion of convertible note payable, amount 50,000 $ 895 49,105 0 0
Sale of common stock, shares   2,000,000      
Sale of common stock, amount 100,674 $ 2,000 98,674 0 0
Amortization of deferred offering cost (8,536) $ 0 (8,536) 0 0
Balance, shares at Jun. 30, 2026   261,585,588      
Balance, amount at Jun. 30, 2026 $ (4,442,816) $ 261,585 $ 77,374,393 $ 0 $ (82,078,794)